Overview
Gisela Sugranyes practices in Barcelona, Spain. Ms. Sugranyes is rated as a Distinguished expert by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Schizophrenia, Anti-NMDA Receptor Encephalitis, Bipolar Disorder (BPD), and Encephalitis.
Her clinical research consists of co-authoring 94 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 42 articles in the study of Schizophrenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anti-NMDA Receptor EncephalitisMs. Sugranyes isDistinguished. Learn about Anti-NMDA Receptor Encephalitis.
- Bipolar Disorder (BPD)Ms. Sugranyes isDistinguished. Learn about Bipolar Disorder (BPD).
- SchizophreniaMs. Sugranyes isDistinguished. Learn about Schizophrenia.
- Advanced
- EncephalitisMs. Sugranyes isAdvanced. Learn about Encephalitis.
- Experienced
- Atelosteogenesis Type 1Ms. Sugranyes isExperienced. Learn about Atelosteogenesis Type 1.
- Attention Deficit Hyperactivity Disorder (ADHD)
- Developmental Dysphasia FamilialMs. Sugranyes isExperienced. Learn about Developmental Dysphasia Familial.
- Nijmegen Breakage SyndromeMs. Sugranyes isExperienced. Learn about Nijmegen Breakage Syndrome.
- Obsessive-Compulsive Disorder (OCD)Ms. Sugranyes isExperienced. Learn about Obsessive-Compulsive Disorder (OCD).